Immunome, Inc.IMNMNASDAQ
Loading
Year-over-year earnings per share growth rate
Percentile
P37
Within normal range
vs 5Y Ago
-0.3x
Contraction
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | -16.92% |
| Q3 2025 | -30.00% |
| Q2 2025 | 3.85% |
| Q1 2025 | 59.38% |
| Q4 2024 | -64.10% |
| Q3 2024 | -30.00% |
| Q2 2024 | 95.22% |
| Q1 2024 | -197.63% |
| Q4 2023 | -1072.22% |
| Q3 2023 | 21.74% |
| Q2 2023 | -39.39% |
| Q1 2023 | 52.17% |
| Q4 2022 | 1.43% |
| Q3 2022 | 5.41% |
| Q2 2022 | 22.92% |
| Q1 2022 | -45.45% |
| Q4 2021 | -1.54% |
| Q3 2021 | -41.30% |
| Q2 2021 | -24.32% |
| Q1 2021 | 7.50% |
| Q4 2020 | 51.81% |
| Q3 2020 | -186.21% |
| Q2 2020 | 38.30% |
| Q1 2020 | 7.84% |
| Q4 2019 | -6.25% |
| Q3 2019 | 78.08% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |